# Evolent

Type: Company (EVH)

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/evolent
Canonical HTML page: https://gethealthbrief.com/entity/evolent

## Timeline

- **2026-02-24**: Earnings Release — Both EVH and LAB report full-year 2025 financial results to the market.
- **2026-01-30**: Asset Realignment — Standard BioTools completes a significant acquisition/disposition of assets per SEC filings.
- **2026-01-08**: Operational Update — Standard BioTools provides preliminary 2025 performance data and strategic outlook.
- **2024-01-05**: SomaLogic Merger — Standard BioTools completes merger with SomaLogic to expand proteomics capabilities.

## Recent coverage (1 stories)

### Evolent and Standard BioTools Q4 Results Signal Strategic Pivot to Profitability
2026-02-24 22:39:32 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Evolent and Standard BioTools reported Q4 and full-year 2025 financial results, highlighting a sector-wide shift toward operational efficiency and consolidation. While Evolent scales its specialty care management platform, Standard BioTools is navigating the final stages of its SomaLogic integration amidst a complex life sciences market.
Full story: https://gethealthbrief.com/story/evolent-standard-biotools-q4-2025-earnings-analysis

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.